1. D Cellular proliferation,
differentiation of lymphocyte, and cellular interactions can take place in bone
marrow (or bursa of Fabricius). However,
antigen-dependent responses occur in the secondary lymphoid organs, such as the
spleen and lymph nodes.
2. C Terminal differentiation of B cells
into plasma cells occurs only in secondary lymphoid organs, such as the spleen
and lymph nodes. Circulation of lymphocytes and cellular
proliferation (but not antigen-dependent responses of terminal differentiation)
also take place in the primary lymphoid organs, such as the bone marrow
and the thymus. The bone marrow is the site where pluripotential
stem cells differentiate into precursor B and T cells.
3. D Innate immunity has none of the
antigenic specificity exhibited by acquired immunity. It is activated by such
stimuli as the invasion of the foreign particles into the body. Innate immunity
involves multiple cell types, such as those of the monocytic
series (macrophages) and those of the granulocytic series (neutrophils,
eosinophils, etc.).
4. D The major function of the lymphoid
system is the recognition of foreign antigen by lymphocytes, which leads to the
acquired immune response. Functions such as phagocytosis
and inflammation do not necessarily require the lymphoid system, and they
constitute part of innate immunity.
5. D Removal of the bursa of Fabricius from a chicken results in low levels of
antibodies in serum, since this organ serves as a primary lymphoid organ in
which B lymphocytes (which eventually synthesize and secrete antibodies)
undergo maturation. The removal of the organ will not result in a marked
decrease in the number of circulating T lymphocytes, nor will it result in
anemia, characterized by a marked decrease in erythrocyte count, since erythrocytes
undergo maturation outside the bursa. Bursectomy has
no effect on rejection of skin grafts
6.
D As discussed in my first lecture and in Chapter 1, germinal centers
are sites in which mature B cells differentiate to plasma cells and undergo
class switch and memory cell formation. Early stages of lymphoid cell
differentiation take place in the primary lymphoid organs. Damaged red blood
cells are removed in the red pulp of the spleen.
7. C The ability to change the heavy chain
constant region while retaining the same antigen specificity is a property
unique to Ig. The other features are common to both
the TCR and Ig.
8. D C3 deficiencies are clinically most
severe and are often associated with immune complex disease and susceptibility
to recurrent bacterial infections. This is due to the fact that C3 plays a
central role in both classical and alternative pathways. C3 can assist in
converting a humoral antibody response into an
effective host defense mechanism. Products of C3 or opsonic
fragments of C3 have receptors on various cells which help in phagocytosis of opsonized
pathogens.
9. C. As discussed in Chapter 2, the
interaction of LFA-1, expressed on leukocytes such as the neutrophil,
with ICAM-1 expressed on the specialized region of the vascular endothelium at
the boundary of lymph nodes, plays a key role in the migration of cells out of
blood and into tissues. The other pairs in the remaining choices are critical
in T cell-antigen presenting cell interactions.
10. E All are correct. The statements are
self-explanatory.
11. A No covalent bonds are
involved in the interaction between antibody and antigen. The binding forces
are relatively weak and include van der Waals forces,
hydrophobic forces, and electrostatic forces. A very close fit between an epitope and the antibody is required.
12. C Three DNA rearrangements are required.
First, D5—>J2 recombination, followed by V17—>
D5J2. This permits synthesis of IgM
and IgD molecules using V17 D5
J2. The third rearrangement is the class switch of V17 D5
J2 Cm Cd—>V17
D5 J2 Cg2, leading to the synthesis of IgG2 molecules.
13. D The
simultaneous synthesis of IgM and IgD
is made possible by the alternate splicing of the primary RNA transcript 5'—
VDJ—Cm— Cd— 3'
14. B MHC class I molecules are expressed
on nearly all nucleated cells, but the constitutive expression of MHC class II
molecules is more limited (B cells, dendritic cells,
and thymic epithelial cells). MHC class II expression
can be induced on other cell types (such as macrophages, endothelial cells, and
human T cells) by cytokines.
15. A As described further in Chapters 9
and 10, the interaction of CD8 on the T cell with an invariant region of the MHC
class I molecule is crucial in the triggering of CD8+ T cells.
16. D The MHC class I molecule, not the
MHC class II molecule, associates with b2- microglobulin.
17. D The products of the TAP-1 and -2
genes selectively transport peptides 8—9 amino acids in length from the
cytoplasm into the ER where they bind to MHC class I molecules.
18. D CD8+ T cells are
generally not activated by processing in acid compartments; exogenous antigen
processing in acid compartments results in the generation of peptides, some of
which can displace the CLIP fragment of the invariant chain from the MHC class
II binding groove. The peptide—MHC class II complexes move to the cell surface
and can interact with a CD4+ T cell with the appropriate receptor.
19. B The b2-microglobulin gene is located
outside the MHC, on a different chromosome.
20. B Regions in the binding pocket or
groove that interact with peptide and the T cell receptor show the greatest
variability in allelic variants.
21. C CD4 expressed on T cells binds to
an invariant or nonpolymorphic region of all MHC
class II molecules.
22. D
Signal joints are cleaved flush at the heptamer with no additional modifications (eg, P or N nucleotides). These modifications as well as exonuclease deletions occur at both VD and VJ coding
junctions. An occasional exception to
the 12/23 spacing rule is D-D joining in humans.
23. A LAD involves an impairment in which
neutrophils, monocytes and
leukocytes are unable to adhere to vascular endothelial cells, thus preventing extravasation of these cells into tissue spaces. Also
impaired are the abilities of CTLs and NK cells to
adhere to their target cells and of helper T cells and B cells to form
conjugates. LAD is due to defective biosynthesis of the b-chain component (CD18) of one
subfamily of integrin adhesion molecules, that
include CR3, CR4 (complement receptors), LFA-1, ICAM-1. The b-chain defect results in a
near-total loss of all these membrane glycoproteins.
Individuals with this defect manifest recurrent bacterial infections (high
white blood count is an indication) and impaired wound healing.
24. C The C1INH (C1-esterase inhibitor)
regulates the activation of the classical pathway by preventing excessive C4
and C2 activation by C1. Without this inhibitor, the activation of C1, C2 and
C4 are uncontrolled resulting in generation of large amounts of vasoactive peptides. These peptides cause increased
permeability of the blood vessels, resulting in localized edema of the tissue.
This deficiency results in a disease called Hereditary Angioedema.
The edema can be in subcutaneous tissues, or within the bowel or upper
respiratory tract, where it causes abdominal pain or obstruction of the airway.
25. F In hyper IgM
type 2 syndrome, AID is mutated. This prevents somatic
hypermutation, and more relevant here, class
switching. Low affinity IgM antibodies accumulate, whereas little to no IgG, IgE or IgA
antibodies are produced. These patients are highly
susceptible to infection with pyogenic (pus-forming)
bacteria such as Streptococcus pyogenes and Haemophilus influenzae
because they are unable to produce an opsonizing
IgG antibody responses to these pathogens. The
polysaccharide capsules of these bacteria are resistant to destruction by
phagocytes unless they are opsonized. IgG is an opsonizing immunoglobulin
because it binds to IgG-specific Fc
receptors expressed by phagocytes. Patients with hyper IgM
syndrome also have defective cell mediated immunity because of an inability of
their macrophages to be optimally activated.
Soon we will talk about
another IgM deficiency syndrome which is X-linked and
results from mutation of CD40L. This
also impairs class switching. Activated
T cells express surface CD40L. CD40L then interacts with CD40, which is
constitutively expressed on the B cell, and this cognate interaction induces B
cell proliferation, differentiation, and heavy chain isotype
switching to IgG, IgA and IgE. T cell derived cytokines also participate in this
class switching.